173 related articles for article (PubMed ID: 38226061)
1. Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey.
Shteinberg M; Spinou A; Goeminne P; Crichton M; Haworth C; Chalmers JD
ERJ Open Res; 2024 Jan; 10(1):. PubMed ID: 38226061
[No Abstract] [Full Text] [Related]
2. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
3. Retail sales of inhalation devices in European countries: so much for a global policy.
Lavorini F; Corrigan CJ; Barnes PJ; Dekhuijzen PR; Levy ML; Pedersen S; Roche N; Vincken W; Crompton GK;
Respir Med; 2011 Jul; 105(7):1099-103. PubMed ID: 21489771
[TBL] [Abstract][Full Text] [Related]
4. Subjective benefit of inhaled therapies in patients with bronchiectasis: a questionnaire study.
O'Neill B; Bradley JM; Macmahon J; Elborn S
Int J Clin Pract; 2004 May; 58(5):441-3. PubMed ID: 15206498
[TBL] [Abstract][Full Text] [Related]
5. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma.
Cates CJ; Rowe BH; Bara A
Cochrane Database Syst Rev; 2002; (2):CD000052. PubMed ID: 12076378
[TBL] [Abstract][Full Text] [Related]
6. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma.
Cates C J; Rowe BH
Cochrane Database Syst Rev; 2000; (2):CD000052. PubMed ID: 10796475
[TBL] [Abstract][Full Text] [Related]
7. [Dry powder inhalers in cystic fibrosis].
Steinkamp G
Pneumologie; 2014 Jun; 68(6):378-85. PubMed ID: 24664997
[TBL] [Abstract][Full Text] [Related]
8. Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.
Lavorini F; Mannini C; Chellini E; Fontana GA
Drugs Aging; 2016 Jul; 33(7):461-73. PubMed ID: 27216613
[TBL] [Abstract][Full Text] [Related]
9. Inhaled therapy in cystic fibrosis: agents, devices and regimens.
Agent P; Parrott H
Breathe (Sheff); 2015 Jun; 11(2):110-8. PubMed ID: 26306111
[TBL] [Abstract][Full Text] [Related]
10. Association between inhaler use and risk of haemoptysis in patients with non-cystic fibrosis bronchiectasis.
Jang EJ; Lee CH; Yoon HI; Kim YJ; Kim JM; Choi SM; Yim JJ; Kim DK
Respirology; 2015 Nov; 20(8):1213-21. PubMed ID: 26293490
[TBL] [Abstract][Full Text] [Related]
11. Oral versus inhaled antibiotics for bronchiectasis.
Spencer S; Felix LM; Milan SJ; Normansell R; Goeminne PC; Chalmers JD; Donovan T
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012579. PubMed ID: 29587336
[TBL] [Abstract][Full Text] [Related]
12. Effective inhaled drug administration to mechanically ventilated patients.
Dhand R; Mercier E
Expert Opin Drug Deliv; 2007 Jan; 4(1):47-61. PubMed ID: 17184162
[TBL] [Abstract][Full Text] [Related]
13. Inhaled antibiotics: dry or wet?
Tiddens HA; Bos AC; Mouton JW; Devadason S; Janssens HM
Eur Respir J; 2014 Nov; 44(5):1308-18. PubMed ID: 25323242
[TBL] [Abstract][Full Text] [Related]
14. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.
Cates CJ; Crilly JA; Rowe BH
Cochrane Database Syst Rev; 2006 Apr; (2):CD000052. PubMed ID: 16625527
[TBL] [Abstract][Full Text] [Related]
15. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma.
Cates CC; Bara A; Crilly JA; Rowe BH
Cochrane Database Syst Rev; 2003; (3):CD000052. PubMed ID: 12917881
[TBL] [Abstract][Full Text] [Related]
16. Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study.
Heraganahally S; Howarth TP; Issac S; Lloyd A; Ravichandran SJ; Abeyaratne A; Patel B
BMJ Open Respir Res; 2023 Mar; 10(1):. PubMed ID: 36878611
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of inhaled antibiotics in patients with bronchiectasis.
Vélez-Díaz-Pallarés M; Montero-Llorente B; Parro-Martín MÁ; Martínez-Barros H; Máiz Carro L; Nieto Royo R; Gómez-Lozano A; Menacho-Román M; Álvarez-Díaz A
Pulm Pharmacol Ther; 2022 Feb; 72():102110. PubMed ID: 35032638
[TBL] [Abstract][Full Text] [Related]
18. [Inhaled medication and inhalation devices for lung disease].
Solé A; Girón RM
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():19-24. PubMed ID: 26365729
[TBL] [Abstract][Full Text] [Related]
19. Stepping into small shoes: Gaining user perspective on appropriate administration devices for paediatric medication in India.
Abidi S; Talegaonkar S; Notani S; Pradhan V; Pokharkar V; Popli H; Walsh J; Salunke S
Eur J Pharm Biopharm; 2023 Oct; 191():247-258. PubMed ID: 37689319
[TBL] [Abstract][Full Text] [Related]
20. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma.
Cates CJ; Welsh EJ; Rowe BH
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD000052. PubMed ID: 24037768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
